SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Pin Elisa)
 

Search: WFRF:(Pin Elisa) > Lagheden Camilla > Muehr Laila Sara Arroyo > Antibodies to SARS-...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Antibodies to SARS-CoV-2 and risk of past or future sick leave

Dillner, Joakim (author)
Karolinska Institutet
Elfstroem, K. Miriam (author)
Karolinska Univ Hosp, Karolinska Univ Lab, S-14186 Stockholm, Sweden.
Blomqvist, Jonas (author)
Karolinska Univ Hosp, S-14186 Stockholm, Sweden.
show more...
Eklund, Carina (author)
Karolinska Institutet
Lagheden, Camilla (author)
Karolinska Institutet
Nordqvist-Kleppe, Sara (author)
Karolinska Institutet
Hellström, Cecilia (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Olofsson, Jennie (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik
Andersson, Eni (author)
KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik
Jernbom Falk, August (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Bergström, Sofia (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Hultin, Emilie (author)
Karolinska Institutet
Pin, Elisa (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Månberg, Anna, 1985- (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Nilsson, Peter (author)
KTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab
Hedhammar, My, Professor, 1975- (author)
KTH,Proteinvetenskap
Hober, Sophia, Professor, 1965- (author)
KTH,Proteinvetenskap
Mattsson, Johan (author)
Karolinska Univ Hosp, S-14186 Stockholm, Sweden.
Muehr, Laila Sara Arroyo (author)
Karolinska Institutet
Lundgren, Kalle Conneryd (author)
Karolinska Institutet
show less...
Karolinska Institutet Karolinska Univ Hosp, Karolinska Univ Lab, S-14186 Stockholm, Sweden (creator_code:org_t)
2021-03-04
2021
English.
In: Scientific Reports. - : Springer Nature. - 2045-2322. ; 11:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n=15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered sick leave. For consenting 12,928 healthy hospital employees antibodies to SARS-CoV-2 could be determined and compared to participant sick leave records. Subjects with viral serum antibodies were not at excess risk for future sick leave (adjusted odds ratio (OR) controlling for age and sex: 0.85 [95% confidence interval (CI) (0.85 (0.43-1.68)]. By contrast, subjects with antibodies had an excess risk for sick leave in the weeks prior to testing [adjusted OR in multivariate analysis: 3.34 (2.98-3.74)]. Thus, presence of viral antibodies marks past disease and protection against excess risk of future disease. Knowledge of whether exposed subjects have had disease in the past or are at risk for future disease is essential for planning of control measures.Trial registration: First registered on 02/06/20, ClinicalTrials.gov NCT04411576.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view